FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Fdc Timolol Maleate Ophthalmic Solution Recall

Timolol Maleate Ophthalmic Solution USP, 0

FDC Limited

Risk level
Class II
Reported by FDA
Aug 6, 2025
Recall ID
D-0543-2025
Check your lot numberHow we source this data

Summary

Fdc recalled Timolol Maleate Ophthalmic Solution starting Jul 5, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0543-2025 on Aug 6, 2025. Reason: Defective Container: spike of the cap becomes lodged in the nozzle of the product bottle. Status: Ongoing.

Why it was recalled

Defective Container: spike of the cap becomes lodged in the nozzle of the product bottle.

Product description

Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-05.

Lot numbers, UPCs & expiration codes

Lot#: 083L061, Exp.: 11/2025.

Where it was sold

U.S Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0543-2025
Classification
Class II
Status
Ongoing
Recall initiated
Jul 5, 2025
FDA report date
Aug 6, 2025
Quantity
154,176 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
FDC Limited

Original FDA data

Every field from FDA enforcement report D-0543-2025, exactly as published.

Show all FDA fields
City
Aurangabad, Maharashtra State
Status
Ongoing
Country
India
Event ID
97219
Address
B-8 MIDC Industrial Area
Address (line 2)
Waluj District
Code information
Lot#: 083L061, Exp.: 11/2025.
Report date
Aug 6, 2025
Product type
Drugs
Recall number
D-0543-2025
Classification
Class II
Recalling firm
FDC Limited
Product quantity
154,176 bottles
Reason for recall
Defective Container: spike of the cap becomes lodged in the nozzle of the product bottle.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-05.
Distribution pattern
U.S Nationwide.
Recall initiation date
Jul 5, 2025
Initial firm notification
Letter
Center classification date
Jul 29, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0543-2025, published Aug 6, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls